Advancing precision health with metabolic phenotyping

Advancing precision health with metabolic phenotyping

Feb 18
CEDA welcomes Australian National Phenome Centre (ANPC) researcher and Murdoch University Pro- Vice Chancellor Professor Jeremy Nicholson to address CEDA Trustees on the role of the ANPC in unlocking the long-term health benefits of phenotyping.


Professor Jeremy Nicholson, Executive Director, Australian National Phenome Centre

Event overview

The ANPC, led by Murdoch University, will transform how long and how well people live, not just in Australia, but around the world.  World-leading researchers at Murdoch University’s ANPC plan to revolutionise the diagnosis, prevention and treatment of serious health challenges such as cancer, Alzheimer’s, obesity and Type 2 diabetes.
As health costs continue to spiral and the average age of our population increases, utilising predictive health through phenotyping will unlock a raft of benefits to improve the health and wellbeing of all Australians. Professor Jeremy Nicholson will outline the work that the ANPC will be doing and how this will shape the future of health.


This briefing is by invitation only to CEDA Trustees. Trustees are senior leaders nominated by CEDA member organisations. At CEDA boardroom briefings Trustees hear from an informed, expert guest speaker in a private, small group setting. Invitations to boardroom briefings are a valued benefit of CEDA membership. Chatham House Rule applies.

Meet the speaker

Professor Jeremy Nicholson
Executive Director, Australian National Phenome Centre

Professor Nicholson obtained his BSc from Liverpool University in the UK (1977) and his PhD from King’s College London (St Thomas’s Hospital Medical School) in 1980. Following a series of London University academic appointments he became Head of Biological Chemistry at Imperial College London in 1998 and then Head of the Department of Surgery and Cancer (2009). He was the founding Director of the MRC-NIHR National Phenome Centre in 2102 and has authored 800+ papers and articles on spectroscopy, metabolic biochemistry, and systems medicine. Focus is on the development of translational diagnostic and prognostic molecular phenotyping and computational technologies in personalised healthcare. He is a past and current Clarivate Highly-Cited Researcher in Pharmacology and Toxicology (H index =121). His work has been recognised by numerous awards including: The Royal Society of Chemistry (RSC) Silver (1992) and Gold (1997) Medals for Analytical Science and Analytical Chemistry respectively; The Chromatographic Society Jubilee Silver Medal (1994); The Pfizer Prize for Chemical and Medicinal Technology (2002); The RSC medal for Chemical Biology (2003); The RSC Interdisciplinary Prize (2008); RSC Theophilus Redwood Lectureship (2008); The Pfizer Global Research Prize for Chemistry (2006) and The Semelweiss-Budapest International Prize for Biomedicine (2010), He is a Fellow of the Royal Society of Biology, The Royal Society of Chemistry and The Royal College of Pathologists. In 2010 he was elected Fellow of The UK Academy of Medical Sciences; elected Honorary Lifetime Fellow of the International Metabolomics Society (2012); Honorary Lifetime Member of the US Society of Toxicology (2013); Albert Einstein Professor of the Chinese Academy of Sciences (2014) and recently elected as an Honorary Fellow of the Royal College of Physicians (2018) Honorary Doctor of Science (honoris causa) 2019, HKBU. Professor Nicholson currently holds a dozen honorary professorships and is a consultant for several pharmaceutical, healthcare and technology companies working in the area of metabolic phenotyping and disease diagnosis.

Meet the host

Professor Eeva Leinonen
Vice Chancellor, Murdoch University

Raised in Finland, Murdoch Vice Chancellor Professor Eeva Leinonen is no stranger to the world of innovation. She understands the commercial and educational benefits which flow when universities partner directly with industry and business. 

During her extensive academic career in Europe, the United Kingdom and Australia, Professor Leinonen has championed innovation in all areas of education. Since joining Murdoch University in April 2016, she has aligned the University’s academic focus to the major health, economic and social challenges confronting Western Australia and the nation.

Professor Leinonen moved to Australia in 2012 to serve as Deputy Vice-Chancellor (Academic) at the University of Wollongong. Prior to this she was Vice-Principal (Education) and Professor of Clinical Linguistics at King’s College, University of London. She also served as Deputy Vice-Chancellor at the University of Hertfordshire, UK. 

Kindly hosted by CEDA member:

Trustee event advice - Coronavirus

We at CEDA are proud to regularly convene and engage speakers and audiences as an essential element of our efforts to broaden discussion and debate of the most important policy issues facing Australia. In doing so, our first priority is always the safety and wellbeing of our guests and staff.

With that in mind, CEDA has postponed all Trustee events until 31 May 2020. However CEDA remains true to its purpose of providing platforms to inform and promote debate of critical issues and driving policy solutions and will continue critical discussions for Australia’s economic, social and environmental development through a digital events program including exclusive livestreams, podcasts and video.

Please contact CEDA if you have any concerns. CEDA is closely monitoring the situation and will promptly act on relevant health advice from the Australian government in relation to COVID-19.